GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022Business Wire • 09/11/22
GRAIL to Present Final Multi-cancer Early Detection Data From the Interventional PATHFINDER Study at ESMO Congress 2022Business Wire • 09/08/22
llumina Announces Opportunity to View Live Webcast of Illumina Genomics Forum Innovation Roadmap Session Followed by Investor Conference CallPRNewsWire • 09/08/22
Illumina to appeal after European Commission prohibits $7.1 billion GRAIL acquisitionFox Business • 09/06/22
Illumina Stock Pops After European Regulators Block $8 Billion DealInvestors Business Daily • 09/06/22
Administrative Law Judge Rules in Favor of Illumina in FTC Challenge of GRAIL DealPRNewsWire • 09/01/22
Here is What to Know Beyond Why Illumina, Inc. (ILMN) is a Trending StockZacks Investment Research • 09/01/22
Illumina Genomics Forum to Feature Tennis Legend Chris Evert on the Role Genomics Played in her Cancer FightPRNewsWire • 08/29/22